HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chang-Hao Yang Selected Research

Ischemia

1/2015Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats.
8/2013Transplantation of induced pluripotent stem cells without C-Myc attenuates retinal ischemia and reperfusion injury in rats.
1/2013The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chang-Hao Yang Research Topics

Disease

21Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 02/2002
14Uveitis
08/2022 - 06/2004
12Inflammation (Inflammations)
01/2021 - 04/2005
9Macular Degeneration (Age-Related Maculopathy)
01/2022 - 11/2007
9Macular Edema
01/2022 - 01/2012
9Retinal Perforations
12/2021 - 03/2011
9Anterior Uveitis
01/2017 - 06/2004
6Polypoidal Choroidal Vasculopathy
07/2022 - 11/2012
5Retinal Detachment (Retinal Detachments)
12/2021 - 03/2004
5Vitreous Hemorrhage
05/2014 - 12/2005
4Neoplasms (Cancer)
01/2015 - 10/2003
3Cysts
12/2021 - 06/2010
3Hemorrhage
09/2019 - 06/2009
3Cataract (Cataracts)
01/2018 - 04/2002
3Dyslipidemias (Dyslipidemia)
01/2018 - 01/2016
3Reperfusion Injury
01/2015 - 01/2013
3Ischemia
01/2015 - 01/2013
2Choroidal Neovascularization
01/2022 - 10/2021
2Disease Progression
01/2022 - 06/2004
2Epiretinal Membrane (Epiretinal Membranes)
12/2021 - 01/2012
2Retinal Dystrophies
10/2021 - 11/2020
2Graves Ophthalmopathy
01/2021 - 01/2020
2Vision Disorders (Hemeralopia)
01/2021 - 01/2005
2Retinal Degeneration
01/2021 - 01/2013
2Fibrosis (Cirrhosis)
01/2020 - 01/2012
2Retinal Diseases
11/2014 - 01/2013
2AIDS-Related Complex (ARC)
05/2014 - 12/2005
2Hypoxia (Hypoxemia)
12/2010 - 07/2009
2Endophthalmitis (Ophthalmia)
01/2005 - 10/2004
2Iridocyclitis
01/2005 - 04/2002
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
03/2022
1Diabetes Mellitus
01/2022
1Bietti Crystalline Dystrophy
01/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022
1Blindness (Hysterical Blindness)
10/2021
1Proliferative Vitreoretinopathy
10/2021
1Optic Nerve Diseases (Optic Neuropathy)
10/2021
1Neuroinflammatory Diseases
07/2021
1Rheumatoid Arthritis
01/2021
1Hyperglycemia
08/2020

Drug/Important Bio-Agent (IBA)

26Retinaldehyde (Retinal)IBA
03/2022 - 02/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 01/2012
8AntigensIBA
01/2017 - 06/2004
8Melanins (Melanin)IBA
01/2017 - 06/2004
7Ranibizumab (Lucentis)FDA Link
10/2021 - 01/2019
6Biomarkers (Surrogate Marker)IBA
08/2022 - 01/2019
6Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2006
6Messenger RNA (mRNA)IBA
08/2020 - 06/2004
6Bevacizumab (Avastin)FDA Link
05/2014 - 08/2008
41-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2022 - 11/2012
4ChemokinesIBA
01/2021 - 06/2004
4Bortezomib (Velcade)FDA Link
01/2016 - 06/2012
4NF-kappa B (NF-kB)IBA
01/2015 - 04/2005
4Cysteine (L-Cysteine)FDA Link
01/2014 - 07/2009
3CytokinesIBA
01/2021 - 04/2005
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2020 - 04/2008
3Proteasome InhibitorsIBA
01/2015 - 06/2012
3ChitosanIBA
01/2015 - 01/2013
3OligosaccharidesIBA
01/2015 - 01/2013
2afliberceptIBA
01/2022 - 10/2021
2Streptozocin (Streptozotocin)FDA Link
07/2021 - 01/2019
2Simvastatin (Zocor)FDA LinkGeneric
01/2021 - 01/2020
2Fenofibrate (CiL)FDA LinkGeneric
08/2020 - 10/2019
2Oxygen (Dioxygen)IBA
05/2020 - 11/2007
2MicroRNAs (MicroRNA)IBA
01/2017 - 01/2015
2Fluorescein (Funduscein)FDA LinkGeneric
07/2016 - 10/2003
2EndotoxinsIBA
01/2016 - 06/2012
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015 - 06/2012
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2015 - 10/2003
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2014 - 01/2012
2ImmunosorbentsIBA
01/2012 - 11/2007
2EnzymesIBA
01/2012 - 11/2007
2InterleukinsIBA
12/2005 - 04/2005
2pyrrolidine dithiocarbamic acidIBA
04/2005 - 04/2005
2prolinedithiocarbamate (PDTC)IBA
04/2005 - 04/2005
2Chemokine ReceptorsIBA
04/2005 - 06/2004
1Circular RNAIBA
03/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Laminin (Merosin)IBA
01/2022
1Doxycycline (Periostat)FDA LinkGeneric
10/2021
1Retinal Pigments (Pigments, Visual)IBA
07/2021
1Glucose (Dextrose)FDA LinkGeneric
07/2021
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2021
1Cysteine-Rich Protein 61IBA
01/2021
1N-acetyltryptophanamide (NATA)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021
1astaxanthine (astaxanthin)IBA
08/2020
1Carotenoids (Carotene)IBA
08/2020

Therapy/Procedure

10Therapeutics
08/2022 - 07/2005
9Vitrectomy
01/2020 - 10/2004
5Photochemotherapy (Photodynamic Therapy)
07/2022 - 11/2012
5Traction
12/2021 - 03/2009
5Intravitreal Injections
10/2021 - 07/2009
4Injections
01/2022 - 11/2012
3Transplantation
11/2014 - 01/2009
2Aftercare (After-Treatment)
01/2021 - 01/2005
2Cryotherapy (Therapy, Cold)
05/2014 - 12/2005
2Scleral Buckling
12/2008 - 03/2004